Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,419,331
-$2,939,622 QoQ
Shares Held
3,397,299
+40.6% QoQ
Ownership
2.28%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nantahala Capital Management, LLC holds $599,967,806 across 52 Biotechnology names. MDXG ranks #18 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLNO |
Soleno Therapeutics Inc
|
1,744,124 | $58,393,271 | |
| 2 | SVRA |
Savara Inc
|
7,344,783 | $40,102,515 | |
| 3 | IMUX |
Immunic, Inc.
|
2,506,491 | $27,822,050 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
1,250,452 | $26,159,455 | |
| 5 | LBRX |
Lb Pharmaceuticals Inc
|
1,052,894 | $25,964,366 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
895,481 | $24,258,580 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
|
2,521,936 | $23,504,443 | |
| 8 | FULC |
Fulcrum Therapeutics, Inc.
|
3,050,040 | $23,393,806 |
All Filings in MDXG
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,419,331 | 3,397,299 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,358,953 | 2,416,389 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,236,630 | 1,466,566 | Shares | Sole | 2025-11-14 | |
| 2023-03-31 | $5,214,231 | 1,529,100 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,190,116 | 1,147,524 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||